A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

Clinical trial NCT02669147 · COMPLETED

Trial details

NCT number: NCT02669147
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status: COMPLETED
Study type: OBSERVATIONAL

Castration Resistant Prostate Cancer (CRPC)

Start date: 2016-01-26
Primary completion: 2021-03-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.